Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

ETA receptor antagonist [BQ-123] . sodium salt

 
ALX-155-004-P001 1 mg* 117.00 USD
 
ALX-155-004-P005 5 mg* 435.00 USD
Do you need bulk/larger quantities?
 
Highly potent and selective ETA antagonist.

Product Specification

Sequence:cyclo(D-Asp-Pro-D-Val-Leu-D-Trp . Na)
 
Formula:C31H42N6O7 . Na
 
MW:633.7
 
CAS:136553-81-6
 
Quantity:*Sold as net peptide weight.
 
Purity:≥96%
 
Solubility:Soluble in water.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 3 years after receipt when stored at -20°C. Stock solutions are stable for up to 3 months when stored at -20°C.
 
ALX-155-004
Please mouse over
ALX-155-004

Product Literature References

Endothelin: progress in pharmacology and physiology: W.G. Haynes, et al.; TIPS 14, 225 (1993), (Review), Abstract;
A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells: S. Eguchi, et al.; FEBS Lett. 302, 243 (1992), Abstract;
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor: M. Ihara, et al.; Life Sci. 50, 247 (1992), Abstract;
Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin- A receptor-selective antagonist: R.A. Atkinson & J.T. Pelton; FEBS Lett. 296, 1 (1992), Abstract;
Cyclic pentapeptide endothelin antagonists with high ETA selectivity. Potency- and solubility-enhancing modifications: K. Ishikawa, et al.; J. Med. Chem. 35, 2139 (1992), Abstract;
Identification of a domain of ETA receptor required for ligand binding: M. Adachi, et al.; FEBS Lett. 311, 179 (1992), Abstract;

Related Literature

Product Flyers
Antiviral Signaling
Antiviral Signaling
Download as PDF

All new literature pieces

Recommend this page

 
Keep in touch

©2017 Enzo Life Sciences, Inc.,